Recent News: Targeted Therapy

Share
Print
and/or
19 News Items found
In the Lab
Cancer biologist Scott Lowe
Drug Combination Could Boost the Effectiveness of Immunotherapy against Pancreatic Cancer
Studies conducted in mice reveal a potential way to breach the defenses of pancreatic cancer tumors.
In the Lab
Illustration of how PU-PET localizes to tumors
Bull’s-Eye: Imaging Technology Could Confirm When a Drug Is Going to the Right Place
Collaborative team advances a new approach for imaging a drug that’s been developed to stop cancer growth.
Feature
Model of TGF-beta molecule
An Old Protein Gets a New Look: Researchers Target TGF-ß to Make Immunotherapy More Effective
Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
Finding
Alex Kentsis in his lab
Research Uncovers the Genetic Causes of Aggressive Leukemia in Children
Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
Feature
John Mendelsohn
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer
The scientific world lost one of its greats this week. Here, we reflect on his influence.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
Finding
Leukemia cells
Findings from Two Patients Shed New Light on Drug Resistance in AML
A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.
In the Clinic
Man and woman in white lab coats looking at test tubes
Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors
Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.
Feature
A barred Plymouth Rock hen
How a Chicken Helped Solve the Mystery of Cancer
When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.
In the Lab
Light micrograph of white blood cells from a patient with acute myeloid leukemia.
New Drug Developed at MSK Starves Acute Myeloid Leukemia of a Signaling Fix
An innovative collaboration between basic scientists and clinical researchers has led to a promising new drug for AML.